LexDanaLexDanabeta
Inventor

Yuqi JIANG

Inventor
CN

Overview

2→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium25%
LOC0625%
Y02PClimate change mitigation technologies in the production or processing of goods25%
PatentTitleYear
D1114517Sofa202612,054,502Multifunctional immunity-targeted micromolecule anti-cancer medicine Bestazomib (Bestazomib) and preparation method and application thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to SHANDONG HUBBLE KISEN BIOLOGICAL TECH CO LTD (1)· patent assignee history
2024Patents assigned to SHANDONG HUBBLE KISEN BIOLOGICAL TECHNONLOGY CO LTD (1)· patent assignee history
2024–2026Based in CN· patent location history
2026Patents assigned to Acanva Co (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
Acanva Co12026
SHANDONG HUBBLE KISEN BIOLOGICAL TECH CO LTD12024
SHANDONG HUBBLE KISEN BIOLOGICAL TECHNONLOGY CO LTD12024
Locations
LocationPatentsSpan
CN22024–2026